Clinical management of community-acquired pneumonia in adults;Estudio y tratamiento de las neumonías de adquisición comunitaria en adultos

Medicina Clinica

Volumn 133, Issue 2, 2009, Pages 63-73

  Pachón, Jerónimo ^a   Alcántara Bellón, Juan De Dios ^a   Cordero Matía, Elisa ^a   Camacho Espejo, Ángela ^a   Lama Herrera, Carmen ^a   Rivero Román, Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MOXIFLOXACIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; ESCHERICHIA COLI; FUSOBACTERIUM; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; LEGIONELLA PNEUMOPHILA; MORAXELLA CATARRHALIS; MORBIDITY; MORTALITY; MYCOPLASMA PNEUMONIAE; PATHOGENESIS; PATIENT CARE; PREVOTELLA; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL;

EID: 67650257381     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.01.032     Document Type: Article

References (102)

1. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and C.H. Dean Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl 2 2007 S27 S72
2. P.A. Gross, T.L. Barrett, P. Dellinger, P.J. Krause, W.J. Martone, and J.E. McGowan Jr Purpose of quality standars for infectious diseases Clin Infect Dis 18 1994 421 (Pubitemid 24086315)
3. American Thoracic Society Guidelines for the management of adults with community-acquired pneumonia Am J Respir Crit Care Med 63 2001 1730 1754
4. T.M. File Jr Community-acquired pneumonia Lancet 362 2003 1991 2001 (Pubitemid 37548426)
5. R.M. Blázquez, F.J. Espinosa, L. Alemany, R.M. Ramos, J.M. Sánchez-Nieto, and M. Segovia Antimicrobial chemotherapy for legionnaires disease: Levofloxacin versus macrólidos Clin Infect Dis 40 2005 800 806
6. J. Pachón, E. Cordero, and F.J. Caballero Importancia de otros patógenos piógenos clásicos (Staphylococcus aureus, bacilos gramnegativos y otros) en la neumonía adquirida en la comunidad Med Clin (Barc) 110 Suppl 1 1998 65 70 (Pubitemid 128529931)
7. J. Almirall, M. Cabré, and P. Clavé Neumonía aspirativa Med Clin (Barc) 129 2007 424 432 (Pubitemid 47574095)
8. J. Pachón, M.D. Prados, F. Capote, J.A. Cuello, J. Garnacho, and A. Verano Severe community-acquired pneumonia Am Rev Respir Dis 142 1990 369 377
9. J. Carratal, A. Mykietiuk, N. Fernández-Sabé, C. Suárez, J. Dorca, and R. Verdaguer Health care-associated pneumonia requiring hospital admission: Epidemiology, antibiotic therapy, and clinical outcomes Arch Intern Med 167 2007 1393 1399 (Pubitemid 47052438)
10. R. Zalacaín, and V. Sobradillo Pacientes con neumonía comunitaria que no requieren hospitalización Med Clin (Barc) Suppl 2 2001 12 15
11. D.M. Musher, R. Montoya, and A. Wanahita Diagnostic value of microscopic examination of Gra-stained sputum and sputum cultures in patients with bacteremic pneumococal pneumonia Clin Infect Dis 39 2004 165 169 (Pubitemid 38971484)
12. M.D. Smith, P. Derrington, R. Evans, M. Creek, R. Morris, and D.A. Dance Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: A prospective, controlled clinical evaluation J Clin Microbiol 41 2003 2810 2813 (Pubitemid 36842263)
13. E. Pérez-Trallero, C. García de la Fuente, C. García-Rey, F. Baquero, L. Aguilar, R. Dal-Ré Spanish Surveillance Group for Respiratory Pathogens Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain Antimicrob Agents Chemother 49 2005 1965 1972 (Pubitemid 40631613)
14. E. Pérez-Trallero, C. Fernández-Mazarrasa, C. García-Rey, E. Bouza, L. Aguilar, J. García de Lomas the Spanish Surveillance Group for Respiratory Pathogens Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain Antimicrob Agents Chemother 45 2001 3334 3340 (Pubitemid 33107843)
15. R. Pallares, D. Liñares, M. Vadillo, C. Cabellos, F. Manresa, and P.F. Viladrich Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain N Engl J Med 333 1995 474 480
16. B.A. Cunha The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias Med Clin North Am 79 1995 581 597
17. G.L. Drusano, and W.A. Craig Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections J Chemother 9 Suppl 3 1997 38 44 (Pubitemid 27294747)
18. ® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: A review of the continuing development of an innovative antimicrobial agent Journal of Antimicrobial Chemotherapy 53 Suppl S1 2004 i3 i20
19. S. Sethi Infectious exacerbations of chronic bronchitis: Diagnosis and management J Antimicrobial Chemotherapy 43 Suppl A 1999 97 105 (Pubitemid 29123508)
20. P. Ball Therapy for pneumoccal infection at the millenium: Doubts and certainties Am J Med 107 Suppl 1A 1999 77S 85S (Pubitemid 29372765)
21. J.M. Blondeau A review of the comparative in-vitro activities of 12 antimicrobials agents, with a focus on 5 new respiratory quinolones J Antimicrob Chemother 43 Suppl B 1999 1 11 (Pubitemid 29231787)
22. E.J. Perea Levofloxacino, actividad in vitro Enferm Infecc Microbiol Clin 17 Suppl 1 1999 8 13 (Pubitemid 29513111)
23. A. Dalhoff, C. Krasemann, S. Wegener, and G. Tilotson Penicillin-resistant Streptococcus pneumoniae: Review of moxifloxacin activity Clin Infect Dis 32 Suppl 1 2001 S22 S29
24. R. Davidson, R. Cavalcanti, and J.L. Brunton Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia N Engl J Med 346 2002 747 750 (Pubitemid 34983995)
25. R.N. Jones, and M.A. Pfaller Macrolide and fluorquinolone (levofloxacin) resistance among Streptococcus pneumoniae strains. Significant trends from the SENTRY antimicrobial surveillance program (North America 1997-1999) J Antimicrob Chemother 38 2000 4298 4299 (Pubitemid 32233255)
26. C. Urban, N. Rahman, X. Zhao, N. Mariano, S. Segal-Maurer, and K. Drlica Fluorquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy J Antimicrob Chemother 184 2001 794 798 (Pubitemid 32826434)
27. M. Fukuda, and K. Hiramutsu Primary targets of fluorquinolone in Streptococcus pneumoniae Antimicrob Ag Chemother 43 1999 410 412
28. E. Pérez-Trallero, J.M. Marimón, A. González, M. Ercibengoa, and J. Larruskain In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease Clin Infect Dis 41 2005 560 564 (Pubitemid 41099655)
29. S. Sethi Infectious etiology of acute exacerbations of chronic bronchitis Chest 117 Suppl 2 2000 380S 385S (Pubitemid 30314471)
30. G.V. Doern the Alexander Project Collaborative Group Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: Results of a 1992-1993 Western Europe and USA collaborative surveillance study J Antimicrob Chemother 38 1996 59 69 (Pubitemid 126718470)
31. S.L. Berck, J.H. Kalbfleisch the Alexander Project Collaborative Group Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA J Antimicrob Chemother 38 1996 85 96
32. F. Álvarez, E. Bouza, J.A. García-Rodríguez, M.A. Mayer, J. Mensa, and E. Monsó Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica Rev Esp Quimioterap 14 2001 87 96 (Pubitemid 32463555)
33. M.R. Turnak, S.I. Bandak, S.K. Bouchillon, B.S. Allen, and D.J. Hoban Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countries Clin Microbiol Infect 7 2001 671 677 (Pubitemid 34960370)
34. Ramírez de Arellano, and E.J. Perea Actividad comparada de diversos macrólidos sobre cepas de Haemophilus influenzae Rev Esp Quimioterap 13 2000 291 296
35. F.J. Boswell, and R. Wise Advances in the macrolides and quinolones Infect Dis Clin North Am 12 1998 647 668
36. J.A. Sáez-Nieto, and J.A. Vázquez In vitro activities of ketolides HRM 3647 and HRM 3004, levofloxacin and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis Antimicrob Agents Chemother 43 1999 983 984 (Pubitemid 29165776)
37. A. Bauerfeind Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin J Antimicrob Chemother 40 1997 639 651
38. R.J. Fass In vitro activity of Bay 12-8039, a new 8-methoxyquinolone Antimicrob Agents Chemother 41 1997 1818 1824 (Pubitemid 27339896)
39. T. Scülin, C.B. Wennersten, and M.J. Ferraro Susceptibilities of Legionella spp. to newer antimicrobials in vitro Antimicrob Agents Chemother 42 1998 1520 1523 (Pubitemid 28257665)
40. A. Dalhoff In vitro activities of quinolones Exp Opin Invest Drugs 8 1999 123 137 (Pubitemid 29054251)
41. N. Kleinkauf, G. Ackermann, R. Schaumann, and A.C. Rodloff Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria Antimicrob Agents Chemother 45 2001 1896 1899 (Pubitemid 32466370)
42. M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, and D.E. Singer A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250 (Pubitemid 27044625)
43. W.S. Lim, M.M. Van der Eerden, R. Laing, W.G. Boersma, N. Karalus, and G.I. Town Defining acquired pneumonia severity on presentation to hospital: An international derivation and validation study Thorax 58 2003 377 382 (Pubitemid 36560938)
44. A. Capelastegui, P.P. España, J.M. Quintana, I. Areitio, I. Gorordo, and M. Egurrola Validation of a predictive rule for the management of community-acquired pneumonia Eur Respir J 27 2006 151 157 (Pubitemid 43092679)
45. American Thoracic Society Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy Am Rev Respir Dis 148 1993 1418 1426
46. L.A. Mandell, T.J. Marrie, R.F. Grossman, A.W. Chow, R.H. Hyland the Canadian community-acquired pneumonia working group Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society Clin Infect Dis 31 2000 383 421 (Pubitemid 32289568)
47. British Thoracic Society Research Committee and the Public Health Laboratory Service The etiology, management and outcome of severe community-acquired pneumonia on the intensive care unit Respir Med 86 1992 7 13
48. J.H. Bates, G.D. Campbell, A.L. Barron, G.A. McCracken, P.N. Morgan, and E.B. Moses Microbial etiology of acute pneumonia in hospitalized patients Chest 101 1992 1005 1012
49. J.G. Bartlett, S.F. Dowell, L.A. Mandell, T.M. File Jr, D.M. Musher, and M.J. Fine Practice guidelines for the management of community-acquired pneumonia in adults Clin Infect Dis 31 2000 422 425 (Pubitemid 32289569)
50. M.D.J. Arbo, and D.R. Snydman Influence of blood culture results on antibiotic choice in treatment of bacteriemia Arch Intern Med 154 1994 2641
51. D.A. Taryle, D.E. Potts, and S.A. Sahn The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia Chest 74 1978 170 173 (Pubitemid 8404854)
52. J. Oteo, J.L. Alos, and J.L. Gómez-Garcés Sensibilidad in vitro actual de los patógenos respiratorios bacterianos más frecuentes: implicaciones clínicas Med Clin (Barc) 116 2001 541 549
53. M.J. Bertrán, A. Trilla, C. Codina, X. Carné, M. Ribas, and M.A. Asenjo Análisis de la relación coste-efectividad del tratamiento antibiótico empírico en pacientes con infecciones del tracto respiratorio inferior adquiridas en la comunidad Enfer Infecc Microbiol Clin 18 2000 445 451 (Pubitemid 32101698)
54. A. Torres, and N. Soler Revisión de las diferentes normativas sobre el tratamiento de la neumonía adquirida en la comunidad Med Clin (Barc) Monogr 2 2001 80 86
55. D. Ben-David, and E. Rubinstein Appopriate use of antibiotics for respitarory infections. Review of recent statement and position papers Curr Op Infect Dis 15 2002 151 156 (Pubitemid 34271158)
56. J. Dorca Sargatal, S. Bello Dronda, J.M. Blanquer Olivas, M.R. Celis Valeri, L. Molinos Martí, and A. Torres Martí Diagnóstico y tratamiento de la neumonía adquirida en la comunidad Arch Bronconeumol 33 1997 240 246
57. R.C. Read Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia J Infect 39 1999 171 178 (Pubitemid 30099559)
58. T.M. File Judicious use of antibiotics to treat respiratory tract infections Curr Op Infect Dis 15 2002 149 150
59. Bjerre LM, Verheij TJM, Kochen MM. Antibióticos para la neumonía adquirida en la comunidad en pacientes adultos ambulatorios (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007, número 2. Oxford: Update Software Ltd.
60. BTS Guidelines for the Management of Community-Acquired Pneumonia in Adults. Thorax 2001;56(Suppl 4):IV1-64.
61. BTS Guidelines for the Management of Community-Acquired Pneumonia in Adults Thorax 59 2004 364 366
62. M.S. Niederman Recent advances in community-acquired pneumonia: Inpatient and outpatient Chest 131 2007 1205 1215 (Pubitemid 46608726)
63. J. Pachón, J.D. Alcántara, E. Cordero, C. Lama, A. Rivero por la Sociedad Andaluza de Enfermedades Infecciosas (SAEI) y la Sociedad Andaluza de Medicina Familiar y Comunitaria (SAMFYC) Manejo clínico de las neumonías adquiridas en la comunidad Enferm Infecc Microbiol Clin 21 2003 350 357 (Pubitemid 37169038)
64. H. Ziglam, and R.G. Finch Resistencia antibiótica en el año 2000 Enferm Infecc Microbiol Clin 19 2001 91 92 (Pubitemid 33020923)
65. T.P. Meehan, M.J. Fine, H.M. Krumholz, J.D. Scinto, D.H. Galusha, and J.T. Mockalis Quality of care, process, and outcome in elderly with pneumonia JAMA 278 1997 2080 2084 (Pubitemid 28016230)
66. D.S. Battleman, M. Callahan, and H.T. Thaller Rapid antibiotic delivery and appropriate antibiotic selection reduce lenght of hospital stay in patients with community-acquired pneumonia Arch Intern Med 162 2002 682 688
67. L.M. Dunbar, R.G. Wunderink, M.P. Habib, L.G. Smith, A.M. Tennenberg, and M.M. Khashab High-dose, short course levofloxacin for community-acquired pneumonia: A new treatment paradigm Clin Infect Dis 37 2003 752 760 (Pubitemid 37153652)
68. L.M. Dunbar, M.M. Khashab, J.B. Kahn, N. Zadeikis, J.X. Xiang, and A.M. Tennenberg Efficacy of 750 mg, 5 day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens Curr Med Res Opin 20 2004 555 563 (Pubitemid 38525164)
69. A. Torres, and N. Soler Evaluación de la etiología y del abordaje terapéutico de la neumonía adquirida en la comunidad Med Clin (Barc) 116 2001 179 181 (Pubitemid 32396981)
70. European Study on Community-Acquired Pneumonia (ESOCAP) Committee Protocolos diagnósticos terapéuticos para las infecciones extrahospitalarias del tracto respiratorio inferior en el adulto Eur Respir J 11 1998 986 991
71. M.L. Metersky Community-acquired pneumonia: Process of care studies Curr Op Infect Dis 15 2002 69 174
72. Pachón J, Cordero E, Rodríguez MJ. Neumonía de la comunidad. En: Programa de aproximación al diagnóstico: enfermedades infecciosas en atención primaria. Unidad 3. Madrid: Drug Farma; 2000. p. 37-52.
73. L. Bembibre, and F. Lamelo Neumonía adquirida en la comunidad Guías Clínicas 3 2003 1 7
74. Molero JM, Redondo J. Aportaciones en enfermedades infecciosas (II). Infecciones de las vías respiratorias bajas. El Médico Interactivo. Formación Acreditada On-Line. Mayo de 2005-mayo de 2006. [consultado 6/11/2007]. Disponible en: URL: www.elmedicointeractivo.com.
75. C. Chidiac Pneumonies aiguës communautaires: Analyse critique des essais cliniques Mdecine et maladies infectieuses 36 2006 650 666 (Pubitemid 44856167)
76. C.M. Fogarty, P. Buchanan, M. Aubier, M. Baz, D. Van Rensburg, and M. Rangaraju Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: A review International Journal of Infectious Diseases 10 2006 136 147 (Pubitemid 43255601)
77. G.D. Mills, M.R. Oehley, and B. Arrol Effectiveness of β lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Meta-analysis BMJ 330 2005 456 462
78. J.A. Schouten, J.M. Prins, M.J. Bonten, J. Degener, R.E. Janknegt, and J.M.R. Hollander Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia The Netherlands Journal of Medicine 63 2005 323 335
79. Ministerio de Sanidad y Consumo. Agencia Española de Medicamentos y Productos Sanitarios. Nota Informativa. Ref. 2008/04, 21 de febrero de 2008.
80. S.C. Chien, M.C. Rogge, L.G. Gisclon, C. Curtin, F. Wong, and J. Natarajan Pharmacokinetic profile of levofloxacin following once-daily 500-miligram oral or intravenous doses Antimicrob Agents Chemother 41 1997 2256 2260 (Pubitemid 27422222)
81. V. Kalbematter, D. Bagilet, M. Diab, and E. Jaikin Levofloxacino oral frente a ceftriaxona y a amoxicilina-ácido clavulánico intravenoso en el tratamiento de la neumonía de adquisición comunitaria que requiere hospitalización Med Clin (Barc) 115 2000 561 563 (Pubitemid 32049957)
82. A. Castro-Guardiola, A.C. Viejo-Rodríguez, S. Soler-Simón, A. Armengou-Arxé, V. Bisbe-Campany, and G. Peñarroja-Matutano Efficacy and safety of oral and early switch to therapy for community-acquired pneumonia: A randomized controlled trial Am J Med 111 2001 367 374 (Pubitemid 32913669)
83. V. Erard, O. Lamy, P.Y. Bochud, U. Bille, A. Cometta, and T. Calandra Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia Eur J Clin Microbiol Infect Dis 23 2004 82 88 (Pubitemid 38392134)
84. B. Rosón, J. Carratalá, F. Tubau, J. Dorca, J. Liñares, and R. Pallares Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: A randomized study of amoxicillin-clavulanate and ceftriaxone Microb Drug Resist 7 2001 75 85
85. J.A. Ramírez, S. Vargas, G.W. Ritter, M.E. Brier, A. Wright, and S. Smith Early switch from intravenous to oral antibiotics and early hospital discharge: A prospective observational study of 200 consecutive patients with community-acquired pneumonia Arch Intern Med 159 1999 2449 2454 (Pubitemid 29526773)
86. A. Torres, J. Serra-Batlles, A. Ferrer, P. Jiménez, R. Celis, and E. Cobo Severe community-acquired-pneumonia: Epidemiology and prognostic factors Am Rev Respir Dis 144 1991 312 318
87. O. Leroy, P. Saux, J.P. Bedos, and E. Caulin Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors Chest 128 2005 172 183 (Pubitemid 40994470)
88. M. Zervos, L.A. Mandell, P.S. Vrooman, C.P. Andrews, A. McIvor, and R.H. Abdulla Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia Treat Respir Med 3 2004 329 336 (Pubitemid 40045497)
89. L. Baddour, V.L. Yu, and K.P. Klugman Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia Am J Respir Crit Care Med 170 2004 440 444 (Pubitemid 39214620)
90. G. Ortíz-Ruíz, N. Vetter, R. Isaacs, A. Carides, G.L. Woods, and I. Friedland Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: Combined analysis of two multicentre randomized, double-blind studies J Antimicrob Chemother 53 2004 ii59 ii66
91. P. Germaud, J. Poirier, P. Jacqueme, J.C. Guerin, Y. Benard, and C. Boutin Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess: A propor of 57 cases Rev Pneumol Clin 49 1993 137 141 (Pubitemid 23245629)
92. R. Daifuku, H. Movahhed, N. Fotheringham, M.B. Bear, and S. Nelson Time to resolution of morbidity: An endpoint for assessing the clinical cure of community-acquired pneumonia Respir Med 90 1996 587 592 (Pubitemid 26385887)
93. J.A. Ramírez, L. Srinath, S. Ahkee, A. Huang, and M.J. Raff Early switch from intravenous to oral cephalosporins in the treatment of hospitalised patients with community-acquired pneumonia Arch Intern Med 155 1995 1273 1276
94. E.A. Halm, M.J. Fine, T.J. Marrie, C.M. Coley, W.N. Kapoor, and D.S. Obrosky Time to clinical stability in patients hospitalized with community-acquired pneumonia: Implications for practice guidelines JAMA 279 1998 1452 1457 (Pubitemid 28228202)
95. R. Menéndez, A. Torres, F. Rodríguez de Castro, R. Zalacaín, J. Aspa, and J. Martín Villasclaras Reaching stability in community-acquired pneumonia: The effects of the severity of disease, treatment, and the characteristics of patients Clin Infect Dis 39 2004 1783 1790 (Pubitemid 39657257)
96. J.A. Ramírez, and J. Bordón Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia Arch Intern Med 161 2001 848 850 (Pubitemid 32225393)
97. M.M. Van der Eerden, F. Vlaspolder, C.S. De Graaff, T. Groot, W. Bronsveld, and H.M. Jansen Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: A prospective randomised study Thorax 60 2005 672 678 (Pubitemid 41129066)
98. Guidelines for the Diagnosis and Management of Community-Acquired neumonia Spanish Society of Pulmonology Thoracic Surgery (SEPAR) Arch Bronconeumol 41 2005 272 289
99. D.C. Rhew, M.S. Riedinger, M. Sandhu, C. Bowers, N. Greengold, and S.R. Weingarten A prospective, multicenter study of a pneumonia practice guideline Chest 14 1998 115 119 (Pubitemid 28337371)
100. E.A. Halm, G.E. Switzer, B.S. Mittman, M.B. Walsh, C.C. Chang, and M.J. Fine What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med 16 2001 599 605 (Pubitemid 32823890)
101. Vacunación contra la gripe 2008. [consultado 21/12/2008]. Disponible en: URL: http://www.juntadeandalucia.es/servicioandaluzdesalud/ principal/documentosAcc.asp?pagina=gripe2008
102. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46:1-24.